Mid American Wealth Advisory Group, Inc. Abb Vie Inc. Transaction History

Mid American Wealth Advisory Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $6,492 - $8,080	-49 Reduced 0.65%	7,434 $1 Billion
Q1 2022 May 31, 2022	SELL	$131.98 - $163.75 $167,878 - $208,290	-1,272 Reduced 14.53%	7,483 $1.21 Million
Q4 2021 Feb 16, 2022	BUY	$107.43 - $135.93 $940,549 - $1.19 Million	8,755 New	8,755 $1.19 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mid American Wealth Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Mid American Wealth Advisory Group, Inc. with notifications on news.